Literature DB >> 9497177

Robert H Herman Memorial Award in Clinical Nutrition Lecture, 1997. Mechanisms causing loss of lean body mass in kidney disease.

W E Mitch1.   

Abstract

Loss of lean body mass is common in patients with acute or chronic renal failure but the mechanisms causing this loss are only beginning to be understood. One mechanism involves an inability of uremic patients to activate the critical metabolic responses that maintain protein balance when dietary protein is limited. Metabolic responses to dietary protein restriction include a sharp reduction in the degradation of essential amino acids and protein; changes in protein synthesis are less reliable. If uremia prevents suppression of essential amino acid or protein degradation when dietary protein is reduced by anorexia, negative nitrogen balance and loss of lean body mass will ensue. One complication of uremia, metabolic acidosis, stimulates the degradation of branched-chain amino acids and proteins and therefore blocks the ability of the patient to respond to a low-protein diet. The mechanisms require glucocorticoids and involve increased activity of branched-chain keto acid dehydrogenase and the ubiquitin-proteasome proteolytic pathway; there also is increased transcription of genes encoding components of enzymes involved in the pathways. Besides acidosis, a low insulin concentration and cytokines activate the ubiquitin-proteasome proteolytic pathway. Understanding how proteolysis is activated, including how these genes are stimulated, is important because the same pathways are activated in diabetes, cancer, sepsis, burns, starvation, and muscle denervation. Activation of the ubiquitin-proteasome pathway leads to reduced lean body mass.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9497177     DOI: 10.1093/ajcn/67.3.359

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  15 in total

Review 1.  Energy homeostasis and cachexia in chronic kidney disease.

Authors:  Robert H Mak; Wai Cheung
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

2.  Association of chronic kidney disease with muscle deficits in children.

Authors:  Bethany J Foster; Heidi J Kalkwarf; Justine Shults; Babette S Zemel; Rachel J Wetzsteon; Meena Thayu; Debbie L Foerster; Mary B Leonard
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

Review 3.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 4.  Ghrelin and cachexia in chronic kidney disease.

Authors:  Hajime Suzuki; Akihiro Asakawa; Haruka Amitani; Norifumi Nakamura; Akio Inui
Journal:  Pediatr Nephrol       Date:  2012-07-04       Impact factor: 3.714

5.  Urinary ammonia and long-term outcomes in chronic kidney disease.

Authors:  Marion Vallet; Marie Metzger; Jean-Philippe Haymann; Martin Flamant; Cédric Gauci; Eric Thervet; Jean-Jacques Boffa; François Vrtovsnik; Marc Froissart; Bénédicte Stengel; Pascal Houillier
Journal:  Kidney Int       Date:  2015-03-11       Impact factor: 10.612

6.  High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.

Authors:  Hyun Ju Kim; Jun Yuan; Keith Norris; Nosratola D Vaziri
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

Review 7.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

Review 8.  Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Authors:  Roberto A Rabinovich; Jordi Vilaró
Journal:  Curr Opin Pulm Med       Date:  2010-03       Impact factor: 3.155

Review 9.  Anorexia: aetiology, epidemiology and management in older people.

Authors:  David R Thomas
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

10.  Disease-specific nutrition therapy: one size does not fit all.

Authors:  D D Yeh; G C Velmahos
Journal:  Eur J Trauma Emerg Surg       Date:  2013-02-25       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.